US gives go ahead to Alzheimer's drug

The US food and drug administration has cleared Eisai's Alzheimer's drug, Aricept, to treat severe dementia in patients with the degenerative brain disease.

    Ronald Reagan suffered from Alzheimer's

    The drug, which is also marketed by Pfizer, is already approved to treat mild to moderate dementia in patients of Alzheimer's, which affects roughly 4.5 million mostly older Americans.

    There is no cure for the condition, typified by memory loss and other cognitive impairment that can quickly worsen.

    Alzheimer's is the most common form of dementia.

    Eisai, based in Japan, earlier this month cited growing US sales of the drug thanks to Medicare's new prescription drug benefit for the elderly and disabled.

    It has forecast total Aricept sales at $1.9 billion, for the fiscal year through March 2007. Some analysts have said that estimate is conservative, but company officials have declined to comment.

    SOURCE: Reuters


    YOU MIGHT ALSO LIKE

    Interactive: Plundering Cambodia's forests

    Interactive: Plundering Cambodia's forests

    Meet the man on a mission to take down Cambodia's timber tycoons and expose a rampant illegal cross-border trade.

    The priceless racism of the Duke of Edinburgh

    The priceless racism of the Duke of Edinburgh

    Prince Philip has done the world an extraordinary service by exposing the racist hypocrisy of "Western civilisation".

    China will determine the future of Venezuela

    China will determine the future of Venezuela

    There are a number of reasons why Beijing continues to back Maduro's government despite suffering financial losses.